Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression
- 15 July 1996
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 40 (2) , 151-153
- https://doi.org/10.1016/0006-3223(95)00666-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Local 5HT3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortexPsychopharmacology, 1995
- Role of the dopaminergic system in depressionBiological Psychiatry, 1992
- Antidepressant-like effects of dopamine agonists in an animal model of depressionBiological Psychiatry, 1992
- Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic TerminalsJournal of Neurochemistry, 1990
- The motor effects of bromocriptine ? a reviewPsychopharmacology, 1988
- RESPONSE TO BROMOCRIPTINE DISTINGUISHES BIPOLAR FROM UNIPOLAR DEPRESSIONThe Lancet, 1984
- Bromocriptine in depressionCurrent Medical Research and Opinion, 1982
- Bromocriptine and imipramine in endogenous depressionJournal of Affective Disorders, 1981
- Effects of a Dopamine Agonist Piribedil in Depressed PatientsArchives of General Psychiatry, 1978
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960